The BEET Diabetes Feasibility Trial

The study aims are:

Aim 1: The investigators will engage behavioral health providers (BHPs) to refine the Balanced and Empowered Eating in Diabetes (or the BEET Diabetes Program) for implementation in real-world settings. The rationale for engaging and collaborating with BHPs and practice stakeholders early in the research protocol is based on data that few evidence-based psychological programs have been successfully translated into clinical settings. Once the six BHPs are recruited, they will be randomized to receive training and deliver either the intervention (i.e., the BEET Diabetes Program) or the comparator, Cognitive Behavior Therapy (CBT). Then, the investigators will collaborate with the BHPs to refine the behavior change programs for implementation in their clinical settings.

Aim 2: The investigators will determine the reach and feasibility of the BEET Diabetes Program in real-world settings. After the intervention refinement period, BHPs will implement and deliver either the intervention or the comparator. To evaluate the adoption, implementation, and potential for maintenance of the BEET Diabetes Program in clinical settings, guided by the RE-AIM framework, the study staff will collect data from clinical leaders, providers and staff, and BHPs via REDCap surveys, observation of sessions delivered by BHPs (live or audio recorded sessions) following a detailed checklist, and data extraction on referral rates and provider adoption from the electronic medical record (e.g., gathering data on the number of referrals or orders submitted by providers in their clinic). The investigators will also conduct semi-structured, 60-minute interviews via Zoom to determine perceived program value and potential for maintenance and long-term use of the programs.

Aim 3: The investigators will estimate the effectiveness of the BEET Diabetes Program on patient-reported and clinical outcomes. This is a Phase IIb pilot study to examine research protocol feasibility, intervention acceptability, patient reach, and engagement and estimate intervention effectiveness to finalize the processes and procedures. Patients will be screened and recruited for the study by their BHP in this aim.

• Diabetes Distress - Change in Participant-Reported Outcome (PROs) [Срок оценки: After completion of the 6 CBT sessions and 4-weeks after program completion (time differs by practice, up to 6 months)]
• Diabetes Self-Efficacy - Change in Participant-Reported Outcome (PROs) [Срок оценки: After completion of the 6 CBT sessions and 4-weeks after program completion (time differs by practice, up to 6 months)]
• Depression - Change in Participant-Reported Outcome (PROs) [Срок оценки: After completion of the 6 CBT sessions and 4-weeks after program completion (time differs by practice, up to 6 months)]
• Anxiety - Change in Participant-Reported Outcome (PROs) [Срок оценки: After completion of the 6 CBT sessions and 4-weeks after program completion (time differs by practice, up to 6 months)]
• Change in participant's HbA1c [Срок оценки: Baseline, After completion of the 6 CBT sessions and 4-weeks after program completion (time differs by practice, up to 6 months)]